Literature DB >> 1707466

Acute phase response after myocardial infarction: correlation between serum levels of cytokines and C-reactive protein.

H Tilg1, J Mair, M Herold, W E Aulitzky, P Lechleitner, F Dienstl, C Huber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707466     DOI: 10.1007/bf01649312

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  5 in total

1.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.

Authors:  D H Perlmutter; C A Dinarello; P I Punsal; H R Colten
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction.

Authors:  I Kushner; M L Broder; D Karp
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

4.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.

Authors:  C P Maury; K J Tötterman; C G Gref; C Ehnholm
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

Review 5.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09
  5 in total
  2 in total

1.  Plasma levels of atrial natriuretic peptide and tumor necrosis factor-alpha during transient myocardial ischemia in patients with stable angina.

Authors:  C J Wiedermann; F J Wiedermann; M Herold; H Tilg; N Moes; V Mühlberger; H Beimpold; E Knapp
Journal:  Klin Wochenschr       Date:  1991-12-11

2.  Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro.

Authors:  C J Wiedermann; M Niedermühlbichler; H Braunsteiner; C J Widermann
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.